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Transglutaminase type 2 (TG2) catalyzes the formation of an
-(-glutamyl)-lysine isopeptide bond between adjacent pep-
tides or proteins including those of the extracellular matrix
(ECM). Elevated extracellular TG2 leads to accelerated ECM
deposition and reduced clearance that underlie tissue scarring
and fibrosis. The extracellular trafficking of TG2 is crucial to its
role in ECM homeostasis; however, the mechanism by which
TG2 escapes the cell is unknown as it has no signal leader pep-
tide and therefore cannot be transported classically. Under-
standing TG2 transport may highlight novel mechanisms to
interfere with the extracellular function of TG2 as isoform-spe-
cific TG2 inhibitors remain elusive.Mammalian expression vec-
tors were constructed containing domain deletions of TG2.
These were transfected into three kidney tubular epithelial cell
lines, and TG2 export was assessed to identify critical domains.
Point mutation was then used to highlight specific sequences
within the domain required for TG2 export. The removal of
-sandwich domain prevented all TG2 export. Mutations of
Asp94 and Asp97 within the N-terminal -sandwich domain
were identified as crucial for TG2 externalization. These form
part of a previously identified fibronectin binding domain
(88WTATVVDQQDCTLSLQLTT106). However, siRNA knock-
down of fibronectin failed to affect TG2 export. The sequence
88WTATVVDQQDCTLSLQLTT106 within the -sandwich
domain of TG2 is critical to its export in tubular epithelial cell
lines. The extracellular trafficking of TG2 is independent of
fibronectin.
Elevated tissue transglutaminase (transglutaminase type 2
(TG2)2) activity is associated with abnormal wound healing (1).
This includes liver (2), pulmonary (3), heart (4), and kidney
fibrosis (5) as well as atherosclerosis (6). The process of scarring
and fibrosis is linked to the increased synthesis ofTG2 andmost
importantly increased export of TG2 to the interstitial space.
Once outside the cell TG2 is able to cross-link extracellular
matrix (ECM) proteins such as fibronectin and collagen (7) by
the incorporation of an -(-glutamyl)-lysine dipeptide bond
(8). Studies have shown that this can accelerate the deposition
of available ECM components while at the same time confer
resistance to proteolytic clearance by thematrix metalloprotei-
nase system (9, 10). Taken together, this causes an accumula-
tion of ECM proteins and thus scar tissue (9). Furthermore,
TG2 has an emerging role in the activation of latent TGF-1 in
the scarring process (11) and has also been associated with
interleukin-6 (12) and tumor necrosis factor- activation path-
ways (13).
Inhibition of TG2 in vitro decreases extracellular matrix lev-
els (14), and cells derived fromTG2 knock-outmice have lower
levels of mature ECM (9). In vivo application of TG2 inhibitors
inmodels of chronic kidney disease reduces the development of
glomerulosclerosis and tubulointerstitial fibrosis, preserving
renal function (15, 16). Similar benefits are seen in the TG2
knock-out mouse subjected to unilateral ureteric obstruction
(17).
The pathological role of TG2 in fibrosis is tightly associated
with its trafficking to the extracellular environment (5, 10, 18)
where it has both enzymatic (post-translational ECMmodifica-
tion and activation of cytokines (19, 20)) and non-enzymatic
roles (cell migration, adhesion (21), and growth (1)). However,
the mechanism by which TG2 is trafficked to the extracellular
space remains unknown. The normal secretary pathway for
proteins through the endoplasmic reticulum, Golgi apparatus,
and plasma membrane to the extracellular environment (22)
requires the protein to have a leader sequence. TG2 has no
leader sequence; therefore, it cannot be exported via the Golgi
apparatus (23, 24). Recent studies have highlighted severalmol-
ecules such as fibroblast growth factor-1 and -2 (25) that like
TG2 are exported without a leader sequence. Therefore, TG2
must be trafficked to the cell surface by an alternative (or
unconventional) export mechanism. This mechanism would
likely rely on specific motifs within the TG2 molecule that are
essential to this process.
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Figs. 1–3.
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The aim of this study was to use deletion and point mutation
studies to identify crucial elements within the TG2 molecule
required for its export from renal tubular epithelial cells that
may give an insight to the export pathway. This will provide
new targets for TG2-specific interventional strategies in treat-
ing scarring and fibrosis.
MATERIALS ANDMETHODS
cDNA and Vectors—All constructs were prepared by PCR
using the humanTG2 cDNAas a template (26) using high fidel-
ity PfuTurbo polymerase (Stratagene). Primers for the domain
deletion and point mutation constructs are shown in Table 1.
PCR products were initially inserted in the pENTR Directional
TOPOvector (Invitrogen) before transfer to the pcDNATM6.2/
nTC-Tag-DEST tetracysteine tag vector (Invitrogen). The
pFC14K CMV Flexi HaloTag vector and HaloTag biotin
ligand were obtained from Promega. The identity of all cDNA
constructs was confirmed by DNA sequencing (Core Genomic
Facility of the University of Sheffield) using a T7 promoter
primer and thymidine kinase poly(A) reverse primer.
Cell Culture—OK cells (27) and rat NRK-52E tubular epithe-
lial cells (28) were obtained from the European Cell Culture
Collection. CanineMDCK II cells were a gift fromN. Simmons
(University of Newcastle, Newcastle, UK). All cells were grown
in complete DMEM supplemented with 10% FBS, 100 units/ml
penicillin, and 100 g/ml streptomycin at 37 °C in 5% CO2
atmosphere. To determine basolateral or apical TG2 traffick-
ing, cells were grown in 6-well culture inserts (0.4-m pores,
transparent polyethylene terephthalate membrane, Falcon).
The culturemedium in the inserts represents apical TG2 secre-
tion, and that outside the insert represents basolateral TG2
secretion.
Cell Transfection—Constructed cDNA were transfected in
renal epithelial cells using Amaxa Nucleofector (Amaxa,
Cologne, Germany). All transfections were performed using
the Ingenio electroporation solution (Geneflow, Staffordshire,
UK). Optimized programs were A20 for opossum proximal
tubule cells (OK), L-05 for MDCK II, and X-01 for NRK-52E
cells with 5 g of selected vectors. This approach ensured that
similar levels of transfected TG2 constructs were delivered to
each cell line, and thus comparable increases in TG2 were seen
in each cell line. The cells were grown in a 6-well plate post-
transfection and incubated at 37 °C for 48 h before analysis. 5
g of vector was selected for transfection as it produced TG2
levels within the linear range of TG2 assays (supplemental Fig.
1A) Stable transfectants were selected by blasticidin resistance
(Invitrogen).
Preparation of Cell Lysates—Cells were trypsinized, centri-
fuged at 300 g for 2 min, and homogenized by sonication in
100 l of STE buffer (0.32 M sucrose, 5 mM Tris, 2 mM EDTA,
pH 7.5) containing protease inhibitors (1 mM leupeptin, 1
mM benzamidine, and 1 mM phenylmethylsulfonyl fluoride
(PMSF)).
Preparation of Conditioned Medium—48 h after transfec-
tion, medium was then replaced with 1 ml of serum-free
medium. The medium was collected after 4-h incubation and
centrifuged at 10,000  g. The supernatant was used for
analysis.
Total Transglutaminase Activity in Cell Lysate and Medium—
Total TG2 activity was measured by the incorporation of bio-
tinylated TVQQEL peptide (a unique TG2 substrate) into
casein using a modified ELISA described by Trigwell et al. (29).
96-well plates were precoated with 1 mg/ml casein in 50 mM
sodium carbonate, pH 7.5 and blocked with 250 l of blocking
solution (0.1%BSA in 50mM sodiumcarbonate) at 37 °C for 1 h.
The reaction was started by mixing 50 l of cell lysates or
medium with 150 l of reaction buffer (13.3 mM dithiothreitol,
6.7 mMCaCl2, 10M biotin-TVQQEL in 100mMTris-HCl, pH
8.5) at 37 °C for 1 h. 200 l of diluted Extravidin-peroxidase
(1:5000) in blocking solution were added and incubated for 1 h
at 37 °C. The color was revealed with 200 l of 3,3,5,5-tetra-
methylbenzidine solution. The color development was stopped
with 50 l of 2.5 M H2SO4. Absorbance was read at 450 nm in a
Labsystems Multiskan Ascent plate reader using Genesis Soft-
ware (version 3.05). The TG activity was calculated in units of
TG activity from a TG2 versus absorbance at 450 nm standard
curve (supplemental Fig. 1B) obtained from guinea pig liver
transglutaminase (T006, Zedira).
Immunoblotting—The protein concentrations of cell lysates
and medium were determined using the bicinchoninic acid
(BCA) assay. Lysates (20 g) or 20 l of medium were diluted
with reducing buffer, incubated in a boiling water bath for 5
min, electrophoresed on 5% (fibronectin) or 7.5% (TG2) SDS-
polyacrylamide gels, transferred to nitrocellulose, and probed
with either anti-TG2 (clone cub7402, ab2306, Abcam) or anti-
fibronectin (ab6328, Abcam) antibody. -Actin (Abcam) was
used as a loading control. Antibody binding was revealed using
TABLE 1
Forward and reverse primers (5 to 3 for both) used to generate TG2 deletions and point mutations. The constructs are shown as three-
dimensional schematics in supplemental Fig. 2
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a polyclonal anti-mouse horseradish peroxidase-conjugated
antibody (P0447, Dako) and developed using enhanced chemi-
luminescence (ECL) (BD Biosciences). For the measurements
of TG2 in culture medium, the film was exposed for at least 1 h.
Assay of Extracellular Transglutaminase Activity—Extracel-
lular TG activity was measured by the incorporation of biotin-
ylated cadaverine into fibronectin as described previously (30).
Briefly, cells were harvested after 48 h post-transfection using
EDTA in PBS. 8  104 cells were resuspended in 100 l of
serum-free DMEM containing 0.1 mM biotinylated cadaverine
(Molecular Probes) and placed into a 96-well plate precoated
with fibronectin at 37 °C for 1 h. The reaction was stopped by 5
mM EDTA in PBS. The cells were lysed using 100 l of 0.1%
(w/v) sodium deoxycholate in PBS with 5 mM EDTA. The wells
were blocked with 3% (w/v) BSA followed by incubation with
Extravidin-peroxidase (1:5000). Incorporated biotinylated
cadaverine was revealed using 3,3,5,5-tetramethylbenzidine.
The resulting color was then read in an ELISA plate reader at
450 nm as above and represents the extracellular/cell surface
TG2 activity. Assay linearity was demonstrated by a TG2 stan-
dard curve produced by applying purified guinea pig liver TG2
to wells containing no cells (supplemental Fig. 1C).
Detection of Extracellular Matrix-bound TG2 Antigen—Ex-
tracellular TG2 antigen was measured using a modified quan-
titative ELISA adapted from Achyuthan et al. (31) based on the
ability of TG2 to adhere to fibronectin. 8 104 cells/well were
plated into a fibronectin-coated 96-well plate. Cells were incu-
bated in serum-free DMEM for 2 h at 37 °C and lysed with 0.1%
deoxycholate in 5 mM EDTA. The remaining fibronectin layer
containing TG2 was blocked with 3% BSA followed by incuba-
tion with anti-TG2 monoclonal antibody (cub7402, Abcam;
1:500) at 4 °C overnight. After a 0.1% Tween 20 wash, the wells
were incubated with HRP-conjugated goat anti-mouse IgG
(Dako; 1:1000) at 37 °C for 1 h. The color was revealed by
3,3,5,5-tetramethylbenzidine and read at 450 nm and repre-
sents the extracellular/cell surface TG2 antigen. Assay linearity
and range were shown using a standard curve generated by the
addition of recombinant human TG2 to wells containing no
cells (supplemental Fig. 1D).
Fibronectin Knockdown by siRNA—The cells were cotrans-
fected with 5 g of DNA with 300 nM nonsense siRNA or anti-
fibronectin 1 siRNA (Applied Biosystems) with TG2 cDNA
using the Amaxa Nucleofector. The TG activity of the cell
lysate, extracellular TG activity, antigen, and TG activity in the
culture mediumweremeasured 48 h after transfection, and the
knockdown of fibronectin in the cell lysate was determined by
5% SDS-PAGE in reducing buffer followed byWestern blotting
for fibronectin.
Tracking TG2 with FlAsH-EDT2 Reagent and Co-localiza-
tionAnalysis—To visualize TG2 transport, NRK-52E cells were
grown on sterilized microscope slide coverslips and incubated
with 2.5 M FlAsH-EDT2 reagent (Invitrogen) or CellMask
plasma membrane staining as required (C10046, Invitrogen).
The coverslip was rinsed in PBS and fixed with 4% paraformal-
dehyde. For co-localization, dual immunofluorescence staining
was performed using the following antibodies at a 1:300 dilu-
tion: monoclonal anti-human collagen IV (C1926, Sigma),
rabbit polyclonal human calnexin (endoplasmic reticulum)
(C4731, Sigma), monoclonal anti-Golgi 58K protein
(G2404, Sigma), and monoclonal anti-LAMP-2 (lysosomes)
(SAB1402250, Sigma). Secondary antibodies were polyclonal
anti-rabbit IgG-TRITC (T5268, Sigma) and anti-mouse IgG-
TRITC at 1:500 (T5393, Sigma). Images were acquired on an
Olympus BX-61 microscope using Cell-F software. Where
applicable, images were deconvolved using AutoQuant X2
(Media Cybernetics, Silver Spring, MD) and three-dimen-
sionally rendered using Imaris (Bitplane AG, Zurich,
Switzerland).
Site-directed Mutagenesis—The QuikChange Site-Directed
Mutagenesis kit with PfuTurbo polymerase (Stratagene) was
used according to themanufacturer’s instructions. The forward
and reverse primers were designed as described previously (32).
PCRwas performed for 12 cycles for one pointmutation and 18
cycles for two point mutations.
HaloTag Protein Measurements—HaloTag protein was
measured by ELISA according to the manufacturer’s instruc-
tions. Briefly, 50 l of cell lysate or culture medium was plated
into a 96-well plate and incubated at 37 °C for 1 h. After three
washes with 1% BSA, anti-HaloTag polyclonal antibody
(G9281, Promega; 1:500) was added to the well and incubated
for 1 h at 37 °C. Following three washes with 1% BSA, anti-
rabbit immunoglobulins/HRP (1:1000) were added and incu-
bated for 1 h at 37 °C. The anti-HaloTag protein polyclonal
antibody and anti-rabbit immunoglobulin/HRP binding was
revealed by 3,3,5,5-tetramethylbenzidine and read at 450 nm.
Statistical Analysis—The results were presented as mean 
S.E. and analyzed using one-way analysis of variance followed
by a Bonferroni post hoc test. A p value less than 0.05 was
considered statistically significant.
RESULTS
We engineered five constructs expressing domain deletion
mutants of TG2 (three-dimensional construct images are
shown in supplemental Fig. 2): TG2 lacking the -sandwich
domain (bsw), the -barrel 2 domain (b2), both -barrel
domains (b1b2), the -sandwich and -barrel 2 domains
(bswb2), and the -sandwich and -barrel 1 and 2 domains
leaving just the TG2 core domain (core). Each construct was
transiently transfected in three different tubular epithelial cell
lines (TECs) (OK, NRK-52E, and MDCK II), and the external-
ization of the mutated TG2 was quantified. The standard curve
for each assay used in this study and TG2 andmutant TG2 load
according to the different amount of vector transfected are
shown in supplemental Fig. 1.
Deletion Analysis: Total TG2 Activity and Antigen
Post-transfection—Western blotting for TG2 in cell lysates
demonstrated comparable increases in TG2 with all constructs
and confirmed that appropriately sized proteins were produced
(Fig. 1, A–C). TG activity in the cell lysates (Fig. 1, D–F) also
increased equally for all constructs within each cell line. This
indicated comparable transfection efficiency and that all
domain deletions retained TG activity. Subsequently, TG2
transport could be tracked using extracellular TG activity
assays.
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Deletion Analysis: Extracellular TG Activity and TG2
Antigen—Extracellular TG activity increased between 3- and
4-fold in all three cell lines transfected with full-length TG2
(Fig. 1, G–I), indicating that TG2 is readily trafficked to the
extracellular environment after transfection in TECs. Similarly,
cells transfected with TG2 cDNA with -barrel 2 (b2) and
both -barrel 1 and -barrel 2 domains missing (b1b2) had
the same levels of extracellular TG activity as that of full-length
TG2 in all three cell lines, suggesting that -barrel domains
played no role in TG2 externalization. Measurement of extra-
cellular TG2 antigen in the media by Western blotting con-
firmed that constructs with -barrel 2 (b2) and both -barrel
1 and -barrel 2 domains missing (b1b2) can be exported
comparably with full-length TG2 (Fig. 1, J–L).
FIGURE1. Intra- andextracellular TG2 levels followingdomaindeletion.OK,NRK-52E, andMDCK II renal epithelial cellswere transfectedwith the following
constructs: 1) full-length TG2 (tg), 2) TG2 with -sandwich domain deleted (bsw), 3) TG2 with -barrel 2 deleted (b2), 4) TG2 with -barrel 1 and -barrel 2
domains deleted (b1b2), 5) TG2with both-sandwich and-barrel 2 domains deleted (bwb2), and finally 6) TG2 catalytic core (core). The expression of TG2
is shown byWestern blots in cell lysates 48 h post-transfection (A–C). Total TG activity in cell lysates (D–F), extracellular TG activity (G–I), Western blots for TG2
in culturemedium (J–L), andTGactivity in culturemedium (M–O)weremeasured.wt indicates non-transfection control. Data representmeanvalues S.E.;n
5; *, p 0.05.
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However, when cells were transfected with constructs in
which the -sandwich domain was missing (i.e.bsw,bwb2,
and just core), extracellular TG activity was similar to that in
cells that had not been transfected. This suggests that the trans-
fected deletion mutant of TG2 is not being trafficked and that
-sandwich domain is crucial for TG2 transport.
As it is possible that removing a domainmay not be affecting
TG2 transport but simply its ability to localize to the cell surface
or ECM (which the extracellular TG activity assay used pre-
dominantlymeasures), we repeatedmeasurements of TG activ-
ity and antigen in the culturemedia to ensure that TG2was not
“floating” in the medium post-transport. In all three tubular
epithelial cell lines, the TG2 fraction found in themediummir-
rored measurements of extracellular TG activity both in terms
of activity (Fig. 1, M–O) and antigen (Fig. 1, J–L), confirming
that none of the constructs with -sandwich domain missing
can be detected in the medium.
Mutation Analysis—A previous report by Griffin and
co-workers (33) on TG2 trafficking in transfected COS-7 cells
had suggested that a fibronectin site encompassing the first 7
amino acids of the TG2 -sandwich domain was crucial for
TG2 export. To validate this inTECs,we deleted this site, trans-
fected the construct, and assessed TG2 export as above. The
construct (tg-7a)was transfectedwith efficiency equal to that of
full-length TG2 (tg) and retained full activity (Fig. 2, A and B).
However, the loss of the fibronectin binding site failed to pre-
vent TG2 export (Fig. 2, C–E), suggesting that it is not impor-
tant in TG2 export in tubular epithelial cells.
Examination of the literature revealed a second fibronectin
binding site (88WTATVVDQQDCTLSLQLTT106) in the
-sandwich domain of TG2 (32), although this had not been
implicated in TG2 trafficking. Subsequently, we introduced
two point mutations (Asp94 and Asp97) in this binding domain
that had been shown previously to disable its binding to
fibronectin (32). Constructs containing either one or both
mutations were equally expressed (f1, f2, and f3) and had the
same level of TG activity in the cell lysate as full-length TG2
(Fig. 3,A–F). However, singlemutation of either Asp94 orAsp97
toAla significantly decreased extracellularTGactivity and anti-
gen by 50% (p 0.05), whereas twopointmutation ofAsp94 and
Asp97 totally prevented TG2 export (p  0.05) (Fig. 3, G–I)
includingTG2 in themedia (Fig. 3, J–O). This indicates that this
second fibronectin binding domain is critical for TG2 traffick-
ing in TECs.
Effect of Deletion and Mutation of TG2 Export Sequence in
Stably Transfected NRK-52E Cells—To confirm the results
from deletion andmutation analyses, cloned, stably transfected
NRK-52E cells containing full-length TG2, TG2 with -sand-
wich domain missing (bsw), and two point mutations (Asp94
and Asp97; f3) were selected using blasticidin resistance. The
expression of TG2 antigen (Fig. 4A) and activity (Fig. 4B) in cell
lysates shows stable and comparable incorporation of all con-
structs. Cells expressing TG2 with the -sandwich domain
missing (bsw) and two pointmutations (f3) had no detectable
TG2 antigen or activity outside the cell (Fig. 4, C–E), whereas
cells expressing full-lengthTG2 did. These data arewholly con-
sistent with the transient transfections used previously.
TG2 Co-transport with Fibronectin—To assess whether TG2
is simply co-transported with fibronectin given that the crucial
export sequence has been reported as a novel fibronectin bind-
ing site, we knocked down fibronectin using co-transfection of
FIGURE 2. Effect on TG2 export of removing amino acids 1–7 fibronectin
binding site. OK, NRK-52E, and MDCK II renal epithelial cells were transfected
with full-length TG2 (tg) ormutant TG2 lacking the first 7 amino acids of-sand-
wich domain that constitute a fibronectin binding site (tg-7a). Western blots for
TG2 incell lysatespost-transfectionare shown inA. Total TGactivity in cell lysates
(B), extracellular TG activity (C), Western blots for TG2 in culturemedium (D), and
TG activity in culture medium (E) were measured.wt indicates non-transfection
control. Data representmean values S.E; n 5; *, p 0.05.
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anti-fibronectin siRNA with full-length TG2 (tg-f) in the cells.
Fibronectin knockdown was confirmed byWestern blot analy-
sis (Fig. 5A). Volume densitometry measurements indicated
that fibronectin was decreased by over 80% compared with
fibronectin levels in cells co-transfected with nonsense siRNA
and TG2 cDNA (tg-ns) in all three cell lines used. Measure-
ments of extracellular TG activity, antigen, and TG activity in
culture medium were identical irrespective of fibronectin
knockdown (Fig. 5, B–E). Therefore, TG2 externalization
appears to be independent of cell-secreted fibronectin, and thus
TG2 is not co-transported with fibronectin.
Possible TG2 Externalization Pathways—Transfection with
tetracysteine-tagged TG2 (nTC-Tag-DEST) allowed the use of
FlAsH staining to color TG2 green under fluorescence so its
movement could be tracked in the cell. This was used in com-
bination with CellMask (red) to define the plasma membrane.
TG2 in cells transfected with full-length TG2 and TG2 lacking
the -sandwich can clearly be seen inside the cell possibly in
vesicles (Fig. 6, B and C, white arrow) with nothing visible in
non-transfected cells (Fig. 6A). Following transfection of full-
length TG2, green staining can also be seen between the cells
clearly in the extracellular space (Fig. 6B, yellow arrow) as well
FIGURE 3. Intra- and extracellular TG2 levels following point mutation. OK, NRK-52E, and MDCK II renal epithelial cells were transfected with either 1)
full-lengthTG2 (tg), 2) singlepointmutationofAsp94 toAla (f1), 3) singlepointmutationofAsp97 toAla (f2), or 4) a two-pointmutationof TG2atAsp94 andAsp97
to Ala (f3). TG2 expression is shownbyWestern blots for TG2 in cell lysates post-transfection (A–C). Total TG activity in cell lysates (D–F), extracellular TG activity
(G–I), Western blots for TG2 in culture medium (J–L), and TG activity in culture medium (M–O) were measured. wt indicates non-transfection control. Data
represent mean valuesS.E; n 5; **, p 0.001; *, p 0.05.
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as in the plasma membrane, which appears orange with some
intense yellow spots due to the co-localization of green and red
fluorescence. Neither of these is seen following transfection
with TG2 in which the -sandwich domain was deleted. This
imaging is consistent with the biochemical measurements of
TG activity and antigen both in and out of the cell. To visualize
the direction of TG2 transport, we used collagen IV (red) as a
basolateral marker. Following deconvolution microscopy and
three-dimensional rendering, TG2 (green) was not visible from
above (Fig. 6D,Apical view) but was just visible at the bottom of
the cells from the side (Fig. 6E, Lateral view), whereas basal
views from underneath clearly show TG2 in the same plane as
collagen IV (Fig. 6F). TG2 is therefore being exclusively
exported to the basolateral side of the cells with themost abun-
dant secretion of TG occurring directly under the nucleus.
FIGURE4. Intra- andextracellular TG2 levels inNRK-52Ecells stably trans-
fectedwithmutant and full-lengthTG2.NRK-52E renal epithelial cellswere
selected by blasticidin resistance after transfection with either wild type TG2
(tg), TG2with-sandwichdomaindeleted (bsw), or a two-pointmutationof
TG2 at Asp94 and Asp97 to Ala (f3). Western blots for TG2 in cell lysates are
shown in A, and TG2 in culture medium is shown in B. Total TG activity in cell
lysate (C), extracellular TG activity (D), and TG activity in medium (E) were
measured.wt indicates non-transfection control. *, p 0.05.
FIGURE 5. Intra- andextracellular TG2 levels following fibronectin knock-
down. OK, NRK-52E, and MDCK II renal epithelial cells were co-transfected
with TG2 plus either anti-fibronectin siRNA (tg-f) or nonsense siRNA (tg-ns).
Western blots (WB) were used to show the basal fibronectin (FN) level in the
cell lysate 48 h after transfection (A) with -actin as a loading control. The
values show volume density measurements as a percentage of the fibronec-
tin knockdown. Total TG activity in cell lysates (B), extracellular TG activity (C),
extracellular TG2 antigen (D), and TG activity in culture medium (E) were
measured.wt indicates non-transfection control. n 5; *, p 0.05.
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Co-localization ofTG2 (yellow; orange arrow) with endoplas-
mic reticulum (ER; red arrow) (Fig. 6G) showed that there was
some co-localization of ER with TG2 around the cell nucleus
(orange arrow); however, no peripheral TG2 (green arrow) was
co-localized with ER, and no ER at all was seen near the periph-
ery of these cells. Overall, 28% of the transfected TG2 was co-
localized with the ER. There was only 0.3% co-localization of
TG2 (green) with the Golgi apparatus (red) (Fig. 6H) and only
0.2% co-localization with lysosomes (red) (Fig. 6I), suggesting
that TG2 is not externalized through Golgi- or lysosome-de-
pendent routes.
Direction of TG2 Secretion—To confirm whether TG2 was
being transported basolaterally (i.e. toward the tubular base-
mentmembrane) rather than apically (i.e. into the lumen), cells
were grown in cell culture well inserts. Culture medium inside
the insert represented apical secretion of TG2 and had a TG
activity below the detection limit of the assay. In contrast, TG
activitywas 4mIU/mgof protein in the culturemediumoutside
the cell culture insert, indicating basolateral TG secretion to the
basement membrane (Fig. 7).
Transport Motif—To assess whether the motif 88–106 itself
is enough to target proteins for externalization in tubular epi-
FIGURE 6. Wild type and mutant TG2 fluorescence microscopy with cell organelle imaging. Wild type NRK-52E cells (A, wt) were transfected with a
tetracysteine Tag vector carrying either full length TG2 (B, tg2) ormutant TG2with-sandwich domain deleted (C,bsw). Post-transfection cells were stained
with FlAsH reagent coloring TG2proteins (green) before the plasmamembranewas stained using Cellmask plasmamembrane reagent (red). Co-localization of
TG2 and plasma membrane appears orange.White arrows indicate intracellular TG2 staining, and yellow arrows indicate extracellular TG2 staining. To deter-
mine the direction of TG2 export, TG2 transfected cells were again costained with FlAsH (green) and collagen IV (red). Three-dimensional images were
generated and apical (D), side (E), and basal views (F) acquired. To assess colocalization with cell organelles, TG2 transfected cells were costained using
organelles light (red) for ER. (G), Golgi apparatus (H), and lysosomes (I). Organelles are indicatedby redarrows. InG, thegreenarrow showsperipheral TG2 (green)
and the orange arrow shows TG2 around the cell nucleus that is colocalized with ER (orange). Cell nuclei are stained bluewith DAPI.
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thelial cells, we inserted thismotif, the-sandwich domain, and
the core domain (not transported) into a HaloTag vector and
measured HaloTag protein levels in the cell lysate and culture
medium (Fig. 8). The HaloTag ligand in the cell lysates was
similar among all three constructs, indicating similar transfec-
tion efficiency and production. In contrast, when the HaloTag
ligand was measured in culture medium, HaloTag linked to the
TG2 export motif 88–106 and the TG2 -sandwich domain
was significantly higher than that linked to the core domain
(p 0.05) construct, suggesting that the motif 88–106 is capa-
ble of targeting proteins for externalization independently of
the rest of the -sandwich or TG2.
DISCUSSION
In this study, we found that the N-terminal -sandwich
domain, in particular the amino acid sequence 88–106 within
the -sandwich domain, is crucial for TG2 externalization in
TECs. This finding is consistent across all three cell lines used
with extracellular transglutaminase assessed using three differ-
ent assays. Therefore, one can conclude this is not a cell line-
specific effect or an artifact of a particular assay. As the identi-
fied sequence is not found in any other TG, targeting this
sequence may provide a novel approach to interfere with the
extracellular trafficking of TG2 seen in renal fibrosis.
In performing these studies, we initially expected that the
cells transfected with TG2 mutants that were not exported
would lead to higher TG levels in the cell lysate. However, prac-
tically no difference in total TG activity/antigen in the cell
lysate was found despite the clear differences in TG2 outside
the cell. These data initially appeared contradictory; however,
by calculating the total amounts of TG2 in intracellular and
extracellular compartments (supplemental Fig. 3) rather than
per milligram of protein, it became evident that extracellular
TG2 is only about 5% of the total TG in the cell lysate, and thus
such small relative changes in intracellular TG2 levels would
unlikely be detectable. However, when total intracellular and
extracellular TG2 per well was calculated, two of the three cell
lines did have higher mean intracellular values when trans-
fected with non-exported TG2 constructs, although the differ-
ences were too small to reach statistical significance despite the
multifold changes in extracellular TG2.
We chose to track TG2 by both antigen and activity routes to
ensure robust data. Central to this was ensuring that the
mutants did not have altered TG activity by measuring the
activity in cell lysates. To confirm this, we also produced a TG2
core protein that displayed activity identical to wild type TG2,
confirming that even with all other domains removed the TG2
core retained its activity.
Visualization of cells transfected with a non-exported
mutant of TG2 showed some potential qualitative differences
in addition to those shown in the figures that require further
study. For example, when TG2 was not exported, the intracel-
lular TG2 tended to accumulate in larger and more dense ves-
icle type structures closer to the nucleus. In addition, prior to
confluence, cells transfectedwith non-exportedmutants donot
flatten to the same extent as those with wild type TG2 and thus
appear to have a smaller diameter. This likely relates to the
extracellular role of TG2 in cell adhesion, which is well known
to cause this affect on morphology.
In the literature, four possible pathways have been proposed
for unconventional protein secretion (Fig. 9A) (25). Proteins
that are passed to the extracellular environment can be secreted
through 1) lysosomes, 2) a direct molecular trap, 3) exosomes
derived from multivesicular bodies, and 4) plasma membrane
blebbing. Interleukin-1 is one of the unconventional secretary
proteins linked to intracellular vesicles (34). The vesicles are
positive for LAMP-1 and cathepsin D, which are both classical
markers for lysosomes (35). In co-localization studies, TG2was
not co-localized with lysosomes, and therefore lysosome trans-
port is unlikely to be involved inTG2 externalization. Increased
sodium tolerance protein (Ist2) is another protein that passes
through the plasma membrane without ER-to-Golgi transport
(36). The newly synthesized Ist2 can be visualized by fluores-
cence microscopy, and it localized with ER at peripheral
patches near the plasmamembrane (37). We found that 30% of
the ER stain was co-localized with TG2 (Fig. 6G); however, this
was around the nucleus and consistent with TG2 synthesis at
the ribosomes on the ER membrane, most likely in ER-bound
polyribosomes. Neither ER (Fig. 9, A, panel 3) nor lysosomes
FIGURE7.TG2 isexportedacrossbasolateralmembrane.OK,NRK-52E, and
MDCK II tubular epithelial cells were transfected with TG2 and plated in cell
culture well inserts. TG activity of the culturemediumbelow the insert (baso-
lateral (b)) and within the insert (apical (a)) was measured in the culture
medium. Date represent mean TG activity in units per milligram of protein
S.E. *, p 0.05; n 5.
FIGURE 8. Can TG2 export motif target other proteins for cell export? The
TG2-sandwichdomain (bsw), TG2coredomain (core), and theTG2exportmotif
88–106 (motif) were placed into the HaloTag vector pFC14K CMV. 48 h post-
transfection the amount of HaloTag-labeled protein found in the culture
medium and in cell lysates was assessed by anti-HaloTag polyclonal antibody. L,
cell lysate;M, culturemedium. Data representmeanHaloTag levelsS.E. n 5.
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(Fig. 9A, panel 1) were co-localizedwith TG2 in vesicles around
the subplasma membrane area. In addition, a lack of TG2 was
seen in plasmamembrane blebs (Fig. 9A, panel 4) or exovesicles
by fluorescence microscopy. TG2 externalization is mostly like
linked to a direct molecular trap mechanism (Fig. 9A, panel 2).
Fibroblast growth factor (FGF-2) is a protein without a clas-
sical N-terminal signal peptide, its transmembrane transport is
dependent on the cell surface heparan sulfate proteoglycans,
and the transport involves a direct molecular trap on the cell
surface (38). Recently, TG2 externalization has been related to
the presence of cell surface heparan sulfate proteoglycans such
as syndecan-4 (39) in primary skin fibroblasts as TG2 is known
to bind heparin (40) and heparan sulfate (39). It remains to be
established whether this pathway is relevant to TECs and
whether amino acids 88–106 that make up the TG2 trafficking
motif are critical for heparan sulfate binding (41). The accumu-
lation of TG2 under the plasma membrane in the -sandwich
deletion and TG2 trafficking motif mutants would be consis-
tent with such an exportmechanism aswould the identification
of the TG2 export motif that is an absolute requirement for its
export. Subsequently, identifying the proteins interacting with
this export motif will be essential in determining the precise
nature of themolecular trapmechanism and confirming this as
a route for TG2 export.
Gaudry et al. (33) studied the interaction of fibronectin and
TG2 using confocal microscopy co-localization studies. These
experiments were performed in TG2-transfected COS-7 cells
with cell surface TG2 determined using a-galactosidase assay.
They found that the first 7 amino acids in the N-terminal
-sandwich domain were important for cell surface TG2 with
no binding to fibronectin if removed. In contrast, we report in
TECs that the removal of the first 7 amino acids of the TG2
-sandwich domain did not stop TG2 externalization. These
discrepancies could simplymean that TECs handle TG2 export
differently than fibroblasts. Of relevance, both Gaudry et al.
(33) and we have identified perceived fibronectin binding sites
as important in TG2 trafficking (even though fibronectin does
not appear crucial for export). However, later work by Hang et
al. (32) showed that the removal of amino acids 1–16 of the
N-terminal -sandwich domain did not affect TG2 binding to
fibronectin. Themotif, amino acids 88–106, we have identified
as crucial for TG2 export is an interesting part of the -sand-
wich forming a 5/6 hairpin that is exposed on the surface of
TG2. Asp94 and Asp97 are crucial for the 5/6 hairpin to form
(Fig. 9B), and subsequently the three-dimensional folding here
is also critical TG2 for export. By adding a single mutation that
would partially collapse the loop, we could partially prevent
export, relating export to structure. Simply attaching this
amino acid sequence to the C terminus of another protein (e.g.
HaloTag) seems to target it for export, which confirms that it is
the part of TG2 required for TG2 trafficking. There have been
several hypotheses suggesting that TG2 could be co-trans-
ported with fibronectin; however, our 80% knockdown of
fibronectin by siRNA had no effect on TG2 extracellular traf-
ficking. This not only contradicts these hypotheses but also
implies that the amino acid sequence 88–106 must have addi-
tional binding partners and/or properties. It is likely that this
TG2 export motif can bind to other proteins that contain a
fibronectin-like domain and that this can act as a transmem-
brane binding partner.
Using bioinformatics, we have confirmed that the sequence
88WTATVVDQQDCTLSLQLTT106 is specific to TG2. Two
very similar sequences were identified in two mammalian cell
membrane proteins. The first is the P2X purinoceptor family
(15 of 19 amino acids in commonwithTG2). These proteins are
cell membrane ion channels and are activated by ATP (42–44).
The other is Semaphorin/CD100 antigen (16 of 19 amino acids
in commonwith TG2). This protein belongs to a large family of
secreted and transmembrane proteins that function as repel-
lent signals during axon guidance (45–47). Semaphorin in par-
ticular is interesting as it can be secreted and thus may have
some common elements with TG2 export. However, little is
known about Semaphorin export.
Perhaps unsurprisingly, we found that TG2 is transported
basolaterally into what would be the tubular basement mem-
brane in vivo. This finding is consistent with the function of
TG2 in the cell adhesion process and its role in ECMdeposition
and stabilization (9) that becomepathological in fibrosis (15). In
regard to understanding the process of TG2 trafficking, it may
be helpful if differences can be identified between the basal and
apical membranes in terms of potential transmembrane pro-
teins or channels (9).
In conclusion, TG2 is a proteinwithout a leader sequence. Its
transport to the extracellular environment is important in the
development of renal fibrosis. This export mechanism is
restricted to the basolateral membrane and wholly dependent
on the amino acid sequence 88–106 within the N-terminal
-sandwich domain. Although this motif has fibronectin bind-
ing properties, export is independent of fibronectin. These
findings are consistent across all tubular epithelial cells tested.
Targeting this motif pharmacologically could “lock” TG2 in the
cell, preventing its detrimental functions in chronic kidney
disease.
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